<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Medivation Inc. | Company News & Executive Profiles - MDVN | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/medivation+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Medivation Inc.]]></description>
	<s:counts start="0" returned="10" found="12" />
	<language>en-us</language>
	<item>
		<title><![CDATA[FDA Calendar Updates: Medivation, Pfizer, AstraZeneca]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F152529-fda-calendar-updates-medivation-pfizer-astrazeneca%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Havrilla submits: Below is a summary of updates to the BioMedReports.com FDA Calendar, which includes a database of 288 entries as of 7/30/09. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA....]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 30 Jul 2009 07:41:18 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/mike+havrilla.html"><![CDATA[Mike Havrilla]]></category>
		<category domain="http://resources.bnet.com/topic/medivation+inc..html"><![CDATA[Medivation Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MDVN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">MDVN,PFE</category>
	</item>
	<item>
		<title><![CDATA[Medivation: Q1 Results Aided by Lower Operating Expenses]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F137720-medivation-q1-results-aided-by-lower-operating-expenses%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Zacks.com submits:   By Brian Marckx, CFA Medivation Inc. MDVN reported first quarter 2009 financial results following the market close on May 11, 2009. Revenue came in at $16.34 million, exactly where we had it modeled. Revenue consisted solely of collaboration revenue from Pfizer Inc. PFE. EPS was ($0.19),...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 14 May 2009 08:04:50 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/zacks.com.html"><![CDATA[Zacks.com]]></category>
		<category domain="http://resources.bnet.com/topic/medivation+inc..html"><![CDATA[Medivation Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MDVN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">MDVN,PFE</category>
	</item>
	<item>
		<title><![CDATA[Medivation, Inc. Q4 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-279030.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator instructions. We will go first to Kim Lee [ph] with Wedbush Morgan. Kim Lee &#8211; Wedbush Morgan Good afternoon. Thanks for taking my questions. I have a couple of questions here. The first is what are the trial designs for the two additional Phase 3 Dimebon...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 16 Mar 2009 19:08:12 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/medivation+inc..html"><![CDATA[Medivation Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MDVN</category>
		<category domain="tickers">MDVN</category>
	</item>
	<item>
		<title><![CDATA[Medivation Inc. Q3 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-248223.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator Operator Instructions We&#8217;ll take our first question from Kim Lee with Pacific Growth Equities. Kim Lee &#8211; Pacific Growth Equities  Good afternoon. Thanks for taking my questions. The first couple of questions have to do with the Dimebon program. Just wanted to get a clarification,...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 10 Nov 2008 20:21:14 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/medivation+inc..html"><![CDATA[Medivation Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/medivation+inc..html"><![CDATA[Medivation Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MDVN</category>
		<category domain="tickers">MDVN</category>
	</item>
	<item>
		<title><![CDATA[Medivation's Attitude Warrants a Pullback]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F94437-medivation-s-attitude-warrants-a-pullback%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Medivation MDVN stock spiked last week due to a deal with Pfizer PFE for Alzheimer's and Huntington's disease treatment Dimebon, currently in late-stage trials that are due to be completed in 2010. At one time I had recommended MDVN in my service, so I am quite familiar with the company...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 08 Sep 2008 09:29:28 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/medivation+inc..html"><![CDATA[Medivation Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MDVN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">MDVN,PFE</category>
	</item>
	<item>
		<title><![CDATA[Five Presentations from the Recent Biotech Investment Conference]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F94042-five-presentations-from-the-recent-biotech-investment-conference%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Huckman submits:  Medivation's Presentation: Standing Room Only  A little more than 24 hours after announcing its big, lucrative Alzheimer's drug partnership with Pfizer PFE, Medivation MDVN had the lead-off position (I wonder if they told organizers they'd be a newsmaker) at yesterday's BioCentury/Thomson Reuters biotech investment conference...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 05 Sep 2008 01:12:14 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/amylin+pharmaceuticals+inc..html"><![CDATA[Amylin Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/celgene+corp..html"><![CDATA[Celgene Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/dendreon+corp..html"><![CDATA[Dendreon Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/eli+lilly+%2526+co..html"><![CDATA[Eli Lilly & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/medivation+inc..html"><![CDATA[Medivation Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/orexigen+therapeutics+inc..html"><![CDATA[Orexigen Therapeutics Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMLN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CELG</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DNDN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MDVN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">OREX</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">AMLN,CELG,DNDN,LLY,MDVN,OREX,PFE</category>
	</item>
	<item>
		<title><![CDATA[Pfizer's Found Innovation at Medivation]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F93826-pfizer-s-found-innovation-at-medivation%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Huckman submits:  In late July at a big scientific conference in Chicago, I reported on new, positive data on Medivation's MDVN experimental Alzheimer's drug Dimebon (dim-uh-bahn). In addition to the rest results being compelling, I highlighted the drug because it has an intriguing backstory: Dimebon is an old...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 04 Sep 2008 12:49:49 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/eli+lilly+%2526+co..html"><![CDATA[Eli Lilly & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/medivation+inc..html"><![CDATA[Medivation Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/wyeth.html"><![CDATA[Wyeth]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MDVN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">WYE</category>
		<category domain="tickers">LLY,MDVN,PFE,WYE</category>
	</item>
	<item>
		<title><![CDATA[Medivation, Inc. Q2 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-223546.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator  Operator instructions And our first question will come from Kim Lee with Pacific Growth. Kim Lee &#8211; Pacific Growth  Good afternoon. Two questions for you. First have you had your end of phase II meeting with the FDA yet with regards with Huntington's disease? Lynn...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 02 Sep 2008 22:20:30 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/medivation+inc..html"><![CDATA[Medivation Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MDVN</category>
		<category domain="tickers">MDVN</category>
	</item>
	<item>
		<title><![CDATA[Medivation, Inc. Q1 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-226556.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator  Thank you. Operator instructions We will take our first question from Michael Yee of RBC Capital Markets.  Michael Yee &#8211; RBC Capital Markets  Great. Thanks. Congratulations on the products so far, David. Couple of questions. Just so we have our expectations in reality,...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 23 May 2008 12:02:10 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/medivation+inc..html"><![CDATA[Medivation Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MDVN</category>
		<category domain="tickers">MDVN</category>
	</item>
	<item>
		<title><![CDATA[MDVN, MECA, MGPI, ORBC, PANL, PLPC Have Also Been Added To Naked Short List Today.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200804/ai_n25270715]]></link>
		<description><![CDATA[M2 PRESSWIRE-2 April 2008-BUYINS.NET: MDVN, MECA, MGPI, ORBC, PANL,  PLPC Have Also Been Added To Naked Short List TodayC1994-2008 M2  COMMUNICATIONS LTD    RDATE:02042008    BUYINS.NET, www.buyins.net, announced today that these select  companies have been added to the NASDAQ, AMEX and NYSE naked...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 02 Apr 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/cable.html"><![CDATA[cable]]></category>
		<category domain="http://resources.bnet.com/topic/medivation+inc..html"><![CDATA[Medivation Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MDVN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">MDVN,NDAQ</category>
	</item>
</channel>
</rss>
